October 13, 2025 S&P futures +1.3% in early Monday trading, rebounding after Friday’s sharp selloff that marked the S&P 500’s worst session since early April’s “Liberation Day” drop. Asian equities were broadly weaker overnight, while European markets are posting modest gains. Treasuries are closed for the Columbus Day holiday. The Dollar Index is up 0.1%, […]
ETFsector.com Daily Trading Outlook Read More »
Robbins Geller Rudman & Dowd LLP has stated that individuals who bought or acquired AstraZeneca PLC (NASDAQ: AZN) publicly traded securities during the period from February 23, 2022 to December 17, 2024…
Novo Nordisk and AstraZeneca are two of the leading companies in the pharmaceutical sector. They have both shown robust financial performance in 2024, however, there is a difference between the two.
Comparing Novo Nordisk to AstraZeneca for a better purchase option. Read More »
The stock market will continue to fluctuate, providing unexpected movements that keep investors on their toes.
Predictions for the stock market in 2025. Read More »
The stock market will continue its unpredictable nature, providing surprises and keeping investors anxious.
My top 2 predictions for the stock market in 2025 Read More »
The stock market will continue to exhibit its usual characteristics of fluctuating unpredictably and keeping investors intrigued.
Predictions of the top 2 stock market for 2025. Read More »
AstraZeneca, a pharmaceutical company based in the U.K., made headlines in a negative light due to issues at its operations in China involving Leon Wang, the company’s president in the country.
Should one purchase AstraZeneca stock? Read More »
Avior Wealth Management LLC reduced its stake in AstraZeneca PLC by 8.5% in the third quarter, as disclosed in its latest filing with the Securities and Exchange Commission.
Avior Wealth Management LLC has sold shares of AstraZeneca PLC (NASDAQ:AZN). Read More »
AstraZeneca PLC (AZN) is meeting with management at the ESMO 2024 Conference.
AstraZeneca PLC’s Management will be attending the ESMO 2024 Conference. Read More »
The top court in Europe has made a decision against Apple, requiring the company to pay 13 billion euros ($14.4) in a recent ruling on September 10, 2024.
5 key points to consider before the stock market opens. Read More »
Stay updated with the latests analysis and insights fromm etfsector.com